Evidence map›Paper›PMID 22863756›Full record

ArticleHuman vaccines & immunotherapeutics2012

The detailed analysis of the changes of murine dendritic cells (DCs) induced by thymic peptide: pidotimod(PTD).

Xiaofang Hu, Wei Zhang, Lu Wang, Nan Wan, Bing Wang, Weiwei Li, Hui Hua, Xu Hu, Fengping Shan

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. A chitosan-based nanosystem as pneumococcal vaccine delivery platform.Drug delivery and translational research · 2021
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaofang HuDepartment of Experimental Laboratory, General Hospital of Shenyang Military Command, Shenyang, China. profshan9@163.com
Wei Zhang
Lu Wang
Nan Wan
Bing Wang
Weiwei Li
Hui Hua
Xu Hu
Fengping Shan

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of present research is to analyze the detailed changes of dendritic cells (DCs) induced by pidotimod(PTD). These impacts on DCs of both bone marrow derived DCs and established DC2.4 cell line were assessed with use of conventional scanning electron microscopy (SEM), flow cytometry (FCM), transmission electron microscopy (TEM), cytochemistry assay FITC-dextran, bio-assay and enzyme linked immunosorbent assay (ELISA). We demonstrated the ability of PTD to induce DC phynotypic and functional maturation as evidenced by higher expression of key surface molecules such as MHC II, CD80 and CD86. The functional tests proved the downregulation of ACP inside the DCs, occurred when phagocytosis of DCs decreased, with simultaneously antigen presentation increased toward maturation. Finally, PTD also stimulated production of more cytokine IL-12 and less TNF-α. Therefore it is concluded that PTD can markedly exert positive induction to murine DCs.

Indexed as

Adjuvants, ImmunologicAnimalsB7-1 AntigenB7-2 AntigenDendritic CellsEnzyme-Linked Immunosorbent AssayFlow CytometryImmunohistochemistryInterleukin-12MiceMicroscopy, Atomic ForceMicroscopy, Electron, TransmissionPyrrolidonecarboxylic AcidThiazolidinesTumor Necrosis Factor-alphaAdjuvants, ImmunologicB7-1 AntigenB7-2 AntigenInterleukin-12pidotimodPyrrolidonecarboxylic AcidThiazolidinesTumor Necrosis Factor-alpha

Identifiers

PMID22863756
PMCPMC3579906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.